Trial Profile
An Open-Label, Multicenter, One-Year Extension Of The Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2010
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Migraine
- Focus Adverse reactions
- Sponsors Eisai Inc
- 21 Jun 2010 New trial record